<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03700398</url>
  </required_header>
  <id_info>
    <org_study_id>2017SDU-QILU-06</org_study_id>
    <nct_id>NCT03700398</nct_id>
  </id_info>
  <brief_title>Early Detection of Head and Neck Superficial Squamous Cell Carcinoma in Patients With Esophagus Squamous Cell Carcinoma</brief_title>
  <official_title>Early Detection of Oropharyngeal and Hypopharyngeal Superficial Squamous Cell Carcinoma in Patients With Esophagus Squamous Cell Carcinoma by White Light Imaging and Optical Enhancement(OE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shandong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shandong University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the investigators randomly divide the eligible objects into two groups:1. objects in this
      group will first receive OE endoscopy observation and subsequent white light imaging(WLI)
      observation during oropharynx and hypopharynx; 2. objects in this group will first receive
      WLI observation and subsequent OE observation during oropharynx and hypopharynx. Then, the
      investigators will compare the detect rate of oropharyngeal and hypopharyngeal superficial
      squamous cell carcinoma of two groups to find if OE endoscopy can improve the detect rate of
      oropharyngeal and hypopharyngeal superficial squamous cell carcinoma in esophageal cancer
      patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2017</start_date>
  <completion_date type="Anticipated">February 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>detect rate</measure>
    <time_frame>12 months</time_frame>
    <description>the detect rate of oropharyngeal and hypopharyngeal superficial squamous cell carcinoma</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">214</enrollment>
  <condition>Optical Enhancement Endoscopy</condition>
  <arm_group>
    <arm_group_label>first OE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>First WLI</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>first OE</intervention_name>
    <description>optical enhancement(OE)ï¼Œa kind of electron straining endoscopy</description>
    <arm_group_label>first OE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>first WLI</intervention_name>
    <description>the routine in the clinical practice</description>
    <arm_group_label>First WLI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  order than 18 years old

          -  Previous or current histopathological pathology confirmed the presence of esophageal
             squamous cell carcinoma

        Exclusion Criteria:

          -  Previously confirmed pharynx/oropharyngeal squamous cell carcinoma

          -  Advanced pharynx/hypopharyngeal squamous cell carcinoma

          -  Pregnant women and lactating women

          -  pharyngeal or esophageal stenosis, esophageal varices, or active digestive tract
             hemorrhage influence the observation or fail to obtain pathological diagnosis

          -  Previous chemotherapy or radiation therapy affected observation

          -  Not completed gastroscopy or refused to take biopsy for various reasons

          -  Mental illnesses such as anxiety and depression affect the endoscopic observation

          -  Severe systemic disease, can not tolerate gastroscopy

          -  Refusal to sign informed consent books
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Qilu Hospital of Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yanqing Li, PHD</last_name>
      <phone>86-531-82169236</phone>
      <email>liyanqing@sdu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>September 23, 2018</study_first_submitted>
  <study_first_submitted_qc>October 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2018</study_first_posted>
  <last_update_submitted>October 6, 2018</last_update_submitted>
  <last_update_submitted_qc>October 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shandong University</investigator_affiliation>
    <investigator_full_name>Yanqing Li</investigator_full_name>
    <investigator_title>vice president of Qilu Hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Squamous Cell</mesh_term>
    <mesh_term>Esophageal Squamous Cell Carcinoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

